Fact-checked by Grok 2 weeks ago

Widal test

The Widal test, also known as the Widal agglutination test, is a serological diagnostic assay developed in 1896 by French physician Georges-Fernand Widal to detect antibodies against Salmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid fever, by observing agglutination of bacterial antigens in patient serum.^[1]^[2] The test specifically measures agglutinins—antibodies targeting the O (somatic lipopolysaccharide) and H (flagellar) antigens of S. Typhi—through a process where serial dilutions of serum are mixed with standardized bacterial suspensions, resulting in visible clumping if antibodies are present at significant levels.^[3]^[4] Introduced over a century ago as one of the earliest serological tests for infectious diseases, the Widal test revolutionized typhoid diagnosis in an era before culture-based methods were widespread, relying on the principle of bacterial agglutination first described in the late 19th century.^[5] The procedure typically involves either a rapid slide method for initial screening or a more precise tube agglutination method for quantitative titers, with results interpreted based on thresholds such as an O antigen titer of ≥1:160 or H antigen titer of ≥1:320 in endemic areas, or preferably a fourfold rise in antibody levels between acute and convalescent serum samples taken 7–14 days apart.^[6]^[7] While it remains inexpensive and accessible, requiring minimal equipment, the test's performance is highly context-dependent, performing better in non-endemic settings with low pre-test probability of exposure.^[8] Despite its historical significance, the Widal test is plagued by controversies regarding its diagnostic accuracy, with reported sensitivity ranging from 53% to 87% and specificity from 45% to 96%, often lower in typhoid-endemic regions due to baseline antibody prevalence from prior infections or vaccinations, cross-reactivity with other Enterobacteriaceae, and variability in test kits and protocols.^[5]^[9] Major health organizations, including the CDC and WHO, do not recommend it as a standalone diagnostic tool in favor of blood or bone marrow cultures, PCR, or newer rapid antigen/antibody tests, citing high false-positive rates that can lead to misdiagnosis and inappropriate antibiotic use.^[10]^[11] Nonetheless, it continues to be widely employed in resource-limited settings across Asia, Africa, and Latin America for presumptive typhoid diagnosis during outbreaks or when advanced laboratory facilities are unavailable.^[8]^[1]

Overview

Definition and purpose

The Widal test is an indirect agglutination test that detects agglutinating antibodies, including IgM and IgG, in patient serum against O (somatic lipopolysaccharide) and H (flagellar) antigens of Salmonella enterica serovars Typhi and Paratyphi.^[12]^[13] These antibodies form in response to infection by these bacteria, which cause enteric fevers.^[14] Named after French physician and bacteriologist Georges-Fernand Widal, the test was introduced in 1896 as one of the first serological diagnostics for bacterial infections, revolutionizing the presumptive identification of typhoid fever at a time when culture methods were limited.^[13]^[12] Its primary purpose is to support the diagnosis of typhoid and paratyphoid fevers, especially in resource-limited and endemic settings where access to blood culture or advanced laboratory facilities is restricted, offering a low-cost alternative for initial screening.^[12]^[8] The test's utility in confirming active infection relies on demonstrating a fourfold or greater rise in antibody titers between acute- and convalescent-phase serum samples, typically collected 7–10 days apart, which distinguishes current from past exposure.^[14]^[12]

Principle of the test

The Widal test operates on the principle of bacterial agglutination, a serological reaction in which specific antibodies in the patient's serum bind to corresponding antigens on Salmonella bacteria, resulting in visible clumping that can be observed macroscopically or under low magnification. This antigen-antibody interaction exploits the immune response to infection, where immunoglobulins attach to bacterial surface structures, cross-linking them to form aggregates. The test specifically targets Salmonella enterica serovars Typhi and Paratyphi A/B, the primary causative agents of enteric fever, by using standardized preparations of their O (somatic lipopolysaccharide) and H (flagellar protein) antigens.^[15]^[16] The reaction begins with sensitization, the initial stage where antibodies adhere to multiple antigenic epitopes on the bacterial surface via non-covalent bonds, coating the particles without immediate visible change. This is followed by lattice formation, in which multivalent antibodies—primarily IgM and IgG—bridge adjacent bacteria, creating an extended network of cross-linked complexes that grow into larger structures. The process culminates in visible aggregation, where these lattices precipitate or clump sufficiently to be discerned by the naked eye or simple microscopy, confirming the presence of reactive antibodies. IgM antibodies, predominant in the early acute phase of infection, primarily target the O antigen and facilitate rapid agglutination due to their pentameric structure, while IgG antibodies, appearing later, react more strongly with the H antigen and indicate ongoing or past exposure.^[17]^[15]^[16] This agglutination mechanism provides a qualitative and quantitative measure of antibody titers, with the degree of clumping inversely related to serum dilution, though specificity can be influenced by cross-reactivity with other Salmonella serovars. The test's reliance on these immunological stages ensures detection of humoral immunity against typhoid and paratyphoid pathogens, distinguishing it from non-specific serological responses.^[15]^[16]

Historical background

Invention and early development

The Widal test was invented in 1896 by French physician Georges-Fernand Widal, a graduate of the University of Paris.^[18] This serological diagnostic tool emerged during a period of rampant typhoid fever epidemics across Europe, where the disease caused significant morbidity and mortality in overcrowded urban settings with poor sanitation.^[19] Widal's innovation built upon foundational bacteriological research, including Robert Koch's earlier demonstrations of bacterial agglutination in infectious diseases, which highlighted the potential of immune responses to cause clumping of pathogens.^[20] Widal's test specifically detected antibodies in patient serum that agglutinated Salmonella typhi (then known as Eberth's bacillus after its discoverer Karl Joseph Eberth in 1880), enabling a presumptive diagnosis of typhoid fever without relying solely on clinical symptoms or post-mortem examination.^[21] He first presented his findings on June 26, 1896, to the Medical Society of the Hospitals of Paris, describing how serum from typhoid patients caused rapid clumping of the bacilli when mixed on a slide.^[20] This work was soon published in detail, with an English summary appearing in The Lancet later that year, outlining the test's procedure and preliminary observations on serum reactivity.^[20] Early validation involved applying the test to patients with confirmed typhoid fever, verified through bacterial culture or autopsy findings, where positive agglutination was consistently observed.^[20] In contrast, sera from individuals with other febrile illnesses, such as tuberculosis, typhus, or pneumonia, showed no or minimal agglutination, demonstrating the test's initial specificity for typhoid over these common differentials.^[20] These results established the Widal test as a practical advancement in clinical diagnostics at the time.^[20]

Adoption and modifications

Following its invention in 1896, the Widal test experienced rapid adoption across Europe and the United States by the early 1900s, becoming a key tool for diagnosing typhoid fever amid widespread military and civilian outbreaks. In Europe, it was integrated into public health responses to epidemics, while in the US, the test was routinely applied by the Army Medical Department during conflicts and training camps, such as in the identification of carriers and cases in the post-Spanish-American War era.^[22]^[23] For instance, US Army protocols incorporated the Widal test for serological screening in typhoid-prone environments by the early 1900s, aiding in outbreak control efforts.^[23] Standardization initiatives emerged to address variability in test performance, with the tube agglutination method established as the quantitative standard for titer determination in the early 20th century, building on the original slide-based macroscopic observation technique.^[24] The standard interpretation involves paired acute and convalescent sera to detect a fourfold rise in antibody titers, which improves diagnostic reliability.^[25] Key modifications enhanced the test's utility for specific applications. In the 1930s, Arthur Felix introduced the Vi antigen to the Widal assay, enabling detection of chronic typhoid carriers by measuring antibodies against this capsular polysaccharide, which persists in asymptomatic individuals.^[26] The original slide agglutination method continued to be used as a rapid qualitative screening tool, allowing quicker results through direct observation of clumping on a glass slide, particularly useful in field or emergency diagnostics.^[20] In developed countries, the Widal test's prominence declined after the 1950s with the advent of effective antibiotics like chloramphenicol and widespread typhoid vaccination programs, alongside improved sanitation that reduced incidence.^[27] However, it remains a cornerstone diagnostic in endemic regions of Asia and Africa, where typhoid fever persists due to ongoing transmission challenges.^[28]

Test methodology

Antigens and reagents

The Widal test employs specific antigens derived from Salmonella enterica serovars to detect agglutinating antibodies in patient serum. The primary antigens include the O antigen, which is the somatic lipopolysaccharide from the bacterial cell wall; the H antigen, which is the flagellar protein from motile bacteria; and the Vi antigen, a capsular polysaccharide unique to Salmonella Typhi and used primarily for identifying chronic carriers. Additionally, AH and BH antigens target the H flagellar components of Salmonella Paratyphi A and B, respectively, enabling detection of paratyphoid infections.^[29]^[19] These antigens are prepared as standardized suspensions from pure cultures of Salmonella strains, either in laboratories or obtained commercially to ensure consistency and potency. For the O antigen, bacteria are typically grown on nutrient agar with phenol, harvested, washed in saline, and boiled to kill the organisms and remove flagella, resulting in a stable somatic suspension. The H antigen is derived from motile broth cultures treated with formalin (0.5-1%) to preserve flagella while inactivating the bacteria. Vi antigen preparation involves extracting the capsular material from Vi-positive S. Typhi strains, often via mild precipitation methods, and incorporating it into a suspension suitable for agglutination. AH and BH antigens follow similar formalization processes using Paratyphi strains. Potency controls, such as titration against known antisera, are essential during preparation to maintain diagnostic reliability.^[30]^[31]^[32] Key reagents for the test include the patient's serum, which is serially diluted in normal saline from 1:20 to 1:1280 to determine antibody titers, along with isotonic saline (0.85% NaCl) for preparing these dilutions. Positive controls consist of serum from confirmed typhoid cases with known high antibody levels, while negative controls use saline or serum from healthy individuals to validate non-specific reactions. These controls ensure the test's specificity and help detect any reagent variability.^[30]^[33]^[34] Antigens and reagents are stored at 2-8°C to preserve stability, with suspensions remaining viable until their labeled expiry date when protected from freezing and light exposure. Periodic standardization is required to assess potency, as antigen degradation or batch variations can lead to inconsistent results; this involves routine testing against reference antisera to confirm agglutination endpoints.^[35]^[33]^[2]

Slide agglutination method

The slide agglutination method serves as a rapid qualitative or semi-quantitative screening procedure in the Widal test, designed to detect significant antibody-mediated agglutination against Salmonella antigens in patient serum within 5-10 minutes, prior to more detailed titration. This approach is particularly suited for preliminary assessment in clinical emergencies or resource-constrained field environments, where immediate results can guide initial patient management for suspected enteric fever.^[36] The procedure utilizes a specialized slide or card featuring multiple rings or circles labeled for the standard antigens: O (somatic), H (flagellar) for Salmonella Typhi, and AH, BH for paratyphoid A and B strains, respectively. Serial dilutions of the patient's serum (typically starting from 1:20 to 1:160 or using varying volumes such as 5-80 µL in saline) are placed into the corresponding rings. An equal volume of the specific antigen suspension is added to each serum dilution, and the mixture is gently stirred using a disposable applicator stick to ensure thorough blending without cross-contamination between rings. The slide is then slowly rocked or rotated by hand for 1-2 minutes at ambient temperature, allowing the agglutination reaction to occur without requiring incubation.^[37]^[38] Results are observed macroscopically during or immediately after the rocking period. A positive reaction manifests as visible clumping or formation of large floccules, where the bacterial cells aggregate and settle, clearing the surrounding suspension; this indicates the presence of relevant antibodies at detectable levels. Conversely, a negative result appears as a smooth, even milky suspension with no discernible clumping, suggesting insufficient antibody titers. Distinct floccular patterns may differ by antigen type—coarse for O and AH, finer for H and BH—but the key is the degree of aggregation observed.^[30]^[39] This method's primary advantages lie in its operational simplicity, requiring minimal equipment and no controlled incubation, which facilitates its use in low-resource or point-of-care settings for swift screening of typhoid suspects. It enables healthcare providers to identify cases warranting further confirmatory testing efficiently, though its qualitative nature limits precision for exact titer quantification.^[24]^[40]

Tube agglutination method

The tube agglutination method represents the quantitative standard for the Widal test, designed to measure precise antibody titers against Salmonella enterica serovar Typhi O and H antigens via serial serum dilutions, providing a more accurate assessment than qualitative approaches.^[24] This technique allows for endpoint determination of the highest dilution exhibiting agglutination, essential for establishing diagnostic thresholds.^[2] The procedure begins with preparing twofold serial dilutions of the patient's serum in 0.9% normal saline, typically ranging from 1:20 to 1:1280 across 8-12 tubes per antigen, using clean, dry glass tubes (10 x 75 mm) or V-bottomed microtiter plates for efficiency.^[24]^[2] An equal volume of standardized bacterial antigen suspension—O antigen for somatic antibodies or H antigen for flagellar antibodies—is added to each tube, followed by thorough mixing.^[24] The setups are then incubated, typically at 37°C for 16-20 hours in a water bath for both O and H antigens; some protocols use higher temperatures for the O antigen (e.g., 50°C for 4 hours) and shorter times for H (e.g., 2 hours at 50°C) to better distinguish granular O agglutination from floccular H agglutination.^[24]^[2] Post-incubation, the tubes are centrifuged at approximately 1000 rpm for 5 minutes to form cell sediments.^[24] Macroscopic examination follows by gently dislodging each pellet: complete agglutination manifests as a fragmented, fluffy, or dispersed sediment lacking a solid button; partial agglutination appears granular or flocculent; and no agglutination results in a compact disc or button at the tube bottom.^[24]^[41] To ensure reliability, positive and negative control sera are run concurrently to verify antigen reactivity and rule out non-specific clumping, while low-dilution checks address potential prozone effects from excess antibodies inhibiting visible agglutination.^[42]^[43] This method is often employed after an initial qualitative slide screening to confirm positives and quantify titers.^[24]

Interpretation of results

Titer determination

In the Widal test, the titer represents the reciprocal of the highest serum dilution at which visible agglutination occurs with the specific Salmonella antigen, indicating the presence and concentration of antibodies.^[44] This endpoint is typically defined as the dilution showing at least 50% agglutination, expressed as a ratio such as 1:160, meaning agglutination is observed when the serum is diluted 160-fold.^[16] The measurement of titers involves serial dilution of the patient's serum in a geometric progression (e.g., 1:20, 1:40, 1:80, 1:160, and higher as needed) using the tube agglutination method, where each dilution is mixed with standardized O or H antigen suspensions and incubated to observe the agglutination pattern.^[44] The process continues until no agglutination is visible in further dilutions, establishing the endpoint; separate titers are reported for the O (somatic) and H (flagellar) antigens to reflect distinct antibody responses.^[44] For enhanced diagnostic reliability, paired serum samples are often analyzed: an acute-phase sample collected during the first week of symptoms and a convalescent-phase sample obtained 7–14 days later.^[25] A fourfold or greater rise in titer between these samples (e.g., an O titer increasing from 1:40 to 1:160) signifies a recent infection, as this rise demonstrates an active immune response.^[25] In non-endemic populations without prior exposure or vaccination, normal baseline titers are generally less than 1:40 for both O and H antigens.^[45] However, in endemic regions or among individuals with previous vaccination or asymptomatic exposure, baseline titers may be elevated, commonly reaching 1:80 or higher without indicating active disease.^[45]

Diagnostic criteria

The diagnostic criteria for the Widal test in confirming enteric fever rely on antibody titers measured against Salmonella antigens, interpreted in the context of the patient's clinical presentation and epidemiological setting. For a single serum sample from individuals in non-endemic areas, titers of ≥1:160 for the O antigen or ≥1:200 for the H antigen are generally considered significant and suggestive of acute typhoid fever when accompanied by compatible symptoms. In endemic regions, thresholds such as ≥1:80 for the O antigen or ≥1:160 for the H antigen may be used, but only with strong clinical suspicion, as baseline titers can be elevated due to prior exposure.^[46]^[47] Paired serum samples, collected 7–14 days apart, provide more reliable diagnostic evidence; a fourfold or greater rise in O or H titers between the acute and convalescent samples is indicative of active infection. This approach accounts for individual variability and reduces false positives from chronic carriage or vaccination.^[48]^[49] For paratyphoid fever, elevated titers against paratyphoid-specific antigens—such as ≥1:160 for AH (Paratyphi A) or BH (Paratyphoid B)—support the diagnosis, often in conjunction with O or H elevations for S. Typhi.^[45] The Widal test results must be integrated with clinical symptoms; a positive test bolsters the diagnosis in patients with prolonged fever, abdominal pain, or relative bradycardia, but a negative result does not exclude early-stage infection, as antibodies may not yet be detectable.^[50]

Limitations

Sources of inaccuracy

The Widal test is susceptible to false positive results primarily due to cross-reactivity of antibodies with antigens from other Enterobacteriaceae, such as Escherichia coli and other non-typhoidal Salmonella serotypes, as well as infections like malaria.^[51]^[52] In malaria patients, for instance, up to 14.58% exhibit positive O antigen titers and 10.41% positive H antigen titers, attributed to polyclonal B-cell activation leading to non-specific antibody production.^[52] Additionally, an anamnestic response—reactivation of memory B cells from prior typhoid vaccination or infection—can elevate baseline titers in endemic populations, mimicking active disease.^[53]^[54] False negative outcomes occur when testing is conducted too early in the infection, typically within the first 7 days of symptom onset, before detectable levels of O or H agglutinins develop.^[53] Antibiotic therapy initiated prior to testing can suppress antibody production, further reducing sensitivity.^[55] The prozone effect, arising in sera with excessively high antibody concentrations, inhibits lattice formation and visible agglutination, necessitating serum dilutions to avoid this artifact.^[56]^[43] Technical sources of inaccuracy include variability in antigen preparation and quality, which can lead to inconsistent reactivity, as well as errors in incubation conditions such as suboptimal temperature or duration that affect agglutination visibility.^[18] Reader subjectivity in interpreting endpoint titers also contributes to variability, particularly in slide agglutination where visual assessment is qualitative.^[53] Meta-analyses underscore these issues, reporting pooled sensitivity for the Widal test of 69% (95% CI: 61–75%) and specificity of 83% (95% CI: 77–88%) when using blood culture as the reference standard, with broader ranges of 53–85% sensitivity and 30–96% specificity across studies due to methodological heterogeneity.^[57]^[24] These figures highlight the test's limited reliability as a standalone diagnostic tool.

Factors affecting reliability

The reliability of the Widal test is significantly influenced by whether the test is performed in endemic or non-endemic regions for typhoid fever. In endemic areas, such as parts of South Asia, healthy individuals often exhibit elevated baseline antibody titers due to prior asymptomatic infections or environmental exposure, with anti-H titers of 1:160 or higher observed in up to 1.9% of the population and anti-O titers of 1:160 or higher in 0.2% (a smaller subset). This results in reduced specificity, as titers exceeding 1:160—commonly used as diagnostic cutoffs—may not indicate acute infection but rather chronic or past exposure, complicating interpretation in regions like India and Bangladesh where specificity can drop below 90%.^[58]^[1] In contrast, non-endemic areas typically show lower baseline titers, allowing for higher specificity when standard cutoffs are applied, though the test's overall sensitivity remains limited regardless of setting.^[1] Patient-specific factors further modulate the test's dependability. Prior vaccination with typhoid-paratyphoid A and B (TAB) vaccine can lead to persistent H agglutinins for months or even years, causing false-positive results that mimic active infection.^[53] Immunosuppressed individuals, such as those with underlying conditions impairing antibody production, may experience delayed or absent seroconversion, reducing the test's sensitivity during acute illness.^[59] Age also plays a role, with children under 15 years showing a higher likelihood of false-negative results due to weaker immune responses, as evidenced by negative Widal tests in up to 30% of culture-proven typhoid fever cases.^[60]^[61] The timing of sample collection critically affects outcome reliability, with the test performing best in the second week of illness when O and H agglutinins peak sharply after initial appearance at days 6–12. Testing too early (first week) often yields false negatives due to insufficient antibody buildup, while in chronic carriers, standard O and H antigens may not detect persistent infection, necessitating separate Vi antigen assays for identification.^[30] Laboratory variations, including inconsistent antigen quality across commercial kits, undermine reproducibility and accuracy, with studies showing marked discrepancies in results from brands like Remel and Dialab at common cutoffs (e.g., 1:160). Lack of global standardization exacerbates this, but using paired acute and convalescent sera (7–10 days apart) to detect a fourfold titer rise can enhance diagnostic precision to approximately 80–88%, depending on the kit and population.^[2]^[62]

Clinical applications

Role in typhoid diagnosis

The Widal test serves as an adjunctive diagnostic tool for typhoid fever, particularly in scenarios where blood culture—the gold standard—is unavailable, negative, or delayed due to logistical constraints in resource-limited settings.^[1] It aids in confirming suspicion of Salmonella Typhi infection based on clinical presentation and helps guide empirical antibiotic therapy initiation, such as with ciprofloxacin or azithromycin, while awaiting confirmatory results.^[63] This role is especially relevant in acute cases where rapid decision-making is needed to prevent complications like intestinal perforation.^[64] In the diagnostic workflow, the Widal test is typically integrated as an initial screening via the slide agglutination method for quick results within minutes, followed by the more precise tube agglutination method if the slide test is positive to quantify antibody titers.^[65] This stepwise approach is combined with clinical evaluation, including characteristic features like stepwise fever, relative bradycardia, and rose spots on the trunk, to enhance diagnostic confidence in suspected typhoid cases. Interpretation of results, such as rising titers in paired sera, further supports the diagnosis when aligned with these signs.^[66] The test is widely employed in developing countries, such as India and various African nations, owing to its low cost—typically ranging from $1 to $2 per test—and simplicity, requiring minimal equipment compared to culture methods.^[1] In contrast, it is rarely used in Western countries, where blood and bone marrow cultures predominate due to better laboratory infrastructure and concerns over the Widal's reliability.^[10] Diagnostic evidence indicates that the Widal test supports identification in approximately 70% of culture-confirmed typhoid cases when performed after the first week of illness, with pooled sensitivity around 69% (95% CI: 61–75%) against blood culture reference.^[66]

Epidemiological uses

The Widal test has been employed in population seroprevalence surveys to gauge the burden of typhoid fever in endemic regions, where elevated baseline antibody titers against Salmonella Typhi antigens can indicate prior exposure rates and ongoing transmission. For instance, in a study conducted in Ethiopia, the Widal test was used to assess seroprevalence among subjects with acute febrile illnesses, revealing a prevalence of 22.8% for anti-O and anti-H antibodies at significant titers, highlighting associated risk factors such as poor sanitation and highlighting the test's role in estimating community-level exposure.^[67] In outbreak investigations, the Widal test facilitates rapid identification of case clusters in resource-limited settings, particularly in endemic hotspots, by screening affected populations for rising antibody titers. A notable example occurred during a 2005 typhoid outbreak at a school in India, where the test confirmed 87.75% of suspected cases (86 out of 98 samples) positive at cut-off titers of 1:160 for H antigen and 1:200 for O antigen, aiding in tracing the outbreak to contaminated water sources and implementing control measures.^[68] Although not recommended as a standalone diagnostic by the World Health Organization due to its limitations, the test has been integrated into broader surveillance efforts in high-burden areas.^[69] For detecting chronic carriers, who play a key role in sustaining transmission, the Widal test's Vi antigen component is utilized in targeted screening, especially among high-risk groups like food handlers. Vi serology, often via passive hemagglutination assay, has demonstrated 75% sensitivity and 92% specificity in endemic areas for identifying carriers at titers of 1:160 or higher, enabling preventive interventions such as antimicrobial therapy or exclusion from food preparation. Community-based surveys, such as one in Vietnam involving over 3,200 adults, have applied anti-Vi antibody testing to screen for carriers, though low isolation rates underscore the need for confirmatory methods.^[70]^[71] Despite these applications, the Widal test's epidemiological utility is constrained by its poor specificity in endemic populations, where cross-reactivity with other infections leads to frequent false positives, making it unsuitable for precise incidence measurement. Meta-analyses report average specificity of 73.3% across studies in developing countries, with recommendations to pair it with blood culture or PCR for validation to enhance reliability in surveillance and outbreak responses.^[72]^[73]

References

[1]
Typhoid Fever Diagnosis in Endemic Countries: A Clog in the Wheel ...
Apr 25, 2018 · The Widal test was developed by Georges Ferdinand Widal in 1896 and helps to detect the presence of Salmonella antibodies in a patient's serum.
[2]
The dilemma of widal test - which brand to use? a study of four ...
Feb 8, 2011 · Serodiagnosis of typhoid fever by Widal test based on demonstrating the presence of agglutinins (antibodies) in the serum of an infected patient ...
[3]
Widal agglutination test − 100 years later: still plagued by controversy
We review the significance of the Widal agglutination test in the diagnosis of typhoid fever. Over 100 years since its introduction as a serologic means of ...
[4]
One-Step 2-Minute Test To Detect Typhoid-Specific Antibodies ... - NIH
The Widal test uses a crude assay method to detect antibodies by their ability to agglutinate whole bacterial cells in test tubes.
[5]
Widal agglutination test - 100 years later: still plagued by controversy
Over 100 years since its introduction as a serologic means of detecting the presence of typhoid fever, the Widal test continues to be plagued with controversies ...
[6]
Significance and value of the Widal test in the diagnosis of typhoid ...
The diagnostic value of the Widal test was assessed in an endemic area. The test was done on 300 normal individuals, 297 non-typhoidal fevers and 275 ...
[7]
[PDF] Draft Target Product Profile for Acute Typhoid Fever Surveillance
Oct 23, 2024 · A positive Widal test requires testing acute and convalescent patient serum taken 10 days apart with a 4-fold increase in the antibody titer.
[8]
Typhoid and Paratyphoid Fever | Yellow Book - CDC
Apr 23, 2025 · The Widal test measures antibody titers; it is unreliable but widely used in low- and middle-income countries because of its low cost.
[9]
A comparative study of Widal test with blood culture in the diagnosis ...
Sep 17, 2014 · Widal test has a low sensitivity, specificity and PPV, but it has good NPV which indicates that negative Widal test result have a good ...
[10]
Clinical Guidance for Typhoid Fever and Paratyphoid Fever - CDC
Apr 24, 2024 · Serologic tests, such as the Widal test, are not recommended because of the high rate of false positives. CDC offers testing for Salmonella ...
[11]
[PDF] Sensitivity and specificity of typhoid fever rapid antibody tests ... - IRIS
Conclusion Semiquantitative slide agglutination and single-tube Widal tests performed poorly. TUBEX® and Typhidot® may be suitable when pretest probability is ...
[12]
Serology of Typhoid Fever in an Area of Endemicity and Its ... - NIH
The Widal test, which detects agglutinating antibodies to lipopolysaccharide (LPS) (TO test) and flagella (TH test), was introduced over a century ago and is ...Widal Test · Serotype Typhi Igm Dipstick... · ResultsMissing: authoritative sources
[13]
Widal agglutination test - 100 years later: Still plagued by controversy
Aug 7, 2025 · The Widal test, first described by Georges Fernand Widal in 1896, is based on the agglutination of patient serum with O and H antigens of S. ...
[14]
Typhoid Fever Workup - Medscape Reference
Sep 4, 2025 · The Widal test was the mainstay of typhoid fever diagnosis for decades. It is used to measure agglutinating antibodies against H and O ...Missing: authoritative | Show results with:authoritative
[15]
Evaluation of the Widal tube agglutination test for the diagnosis of ...
Jun 22, 2010 · The test was first introduced by F. Widal in 1896 [2] and is based on a macroscopically visible serum - mediated agglutination reaction between ...
[16]
Typhoid Fever - StatPearls - NCBI Bookshelf - NIH
Apr 19, 2024 · Immunological Tests. The Widal agglutination test is a classic serological test that has been controversial since its development in the late ...<|control11|><|separator|>
[17]
Chapter 6: Immunological (Antigen and Antibody) Reactions ...
Aug 24, 2021 · First, a combination of Ag and Ab leads to lattice formation when a better fit of Ab (IgM & IgG) to antigen gives rise to larger clumps, which ...
[18]
Widal Test - an overview | ScienceDirect Topics
Georges-Fernand-Isidor Widal (1862–1929) used bacterial agglutination to develop a diagnostic test for typhoid fever. Widal studied at the University of ...Missing: invention | Show results with:invention
[19]
Typhoid Fever | New England Journal of Medicine
Typhoid fever was an important cause of illness and death in the overcrowded and unsanitary urban conditions of the United States and Europe in the 19th century ...<|control11|><|separator|>
[20]
[PDF] George Fernand Widal (1862–1929): Serologist and clinician-scientist
He presented these findings to the Medical Society of the Hospitals of Paris on 26 June, 1896 and published a description of the test a few months later in the.Missing: introduction | Show results with:introduction
[21]
History | AMEDD Center of History & Heritage
The Widal test took advantage of the fact that the antibodies to typhoid fever found in the blood serum of victims will cause typhoid bacteria to clump. See ...
[22]
War Department's Creation of the Typhoid Board Headed by Walter ...
... Widal method, the first effective serodiagnostic test for the disease. Using blood samples solicited from military hospitals throughout the nation, Reed ...Missing: adoption Europe
[23]
Maj. Frederick F. Russell - National Museum of Health and Medicine
Aug 19, 2025 · Russell's involvement with typhoid prevention began during his time at the Army Medical Museum, where he served as the seventh curator from 1907 ...Missing: adoption | Show results with:adoption
[24]
Evaluation of the Widal tube agglutination test for the diagnosis of ...
Jun 22, 2010 · Evaluation of the Widal tube agglutination test for the diagnosis of typhoid fever among children admitted to a rural hdospital in Tanzania ...
[25]
Use of Paired Serum Samples for Serodiagnosis of Typhoid Fever
In its original form, the Widal test required two serum samples (acute and convalescent), with a fourfold rise in serum anti-LPS (TO) or anti-flagella (TH) ...
[26]
special articles detection of chronic typhoid carriers by agglutination ...
In 1934, Arthur Felix identified the Vi ag and showed that antibody responses to Vi disappeared from the majority of patients recovering from acute typhoid ...Missing: Widal 1930s
[27]
View of The laboratory diagnosis of enteric fever
Serological diagnosis is predominantly by the Felix-Widal test, first standardised in the 1950s, [5]. Although ELISA [6]and immunoblotting [7]suggest ...Missing: screening | Show results with:screening
[28]
[PDF] Epidemiology of Typhoid Fever
1940s resulted in drastic reduction of typhoid fever morbidity and mortality in industrialized countries. • In developing areas of Asia ,Africa, Latin America, ...
[29]
The Invisible Burden: Diagnosing and Combatting Typhoid Fever in ...
Oct 15, 2019 · South Asia has a long history of typhoid fever, which has been well documented among the more than 1 billion people who lived in India before ...Missing: post- | Show results with:post-
[30]
Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever - NIH
May 25, 2017 · The Widal test (WT) is a serological test that detects agglutinating antibodies to LPS (O antigen) and flagella (H antigen). The WT is the ...
[31]
Widal Test- Introduction, Principle, Procedure, Interpretation and ...
Aug 10, 2022 · Widal Test is an agglutination test which detects the presence of serum agglutinins (H and O) in patients serum with typhoid and paratyphoid ...Missing: lattice formation
[32]
Vi antigen from Salmonella typhosa and immunity against typhoid ...
A Vi preparation was isolated from Salmonella typhosa, the causative organism in human typhoid fever, by a mild precipitation method.
[33]
Modified Vi tests in the screening of typhoid carriers
The bacterial cell suspension used for the Vi-agglutination test was prepared ... Preparation of the Vi bacterial antigen. The Vi bacterial cell antigen was ...
[34]
[PDF] widal positive control - Tulip Diagnostics
The titre of the patient serum using WIDAL antigen suspensions is the highest dilution of the Positive control that gives a visible agglutination.
[35]
[PDF] WIDAL TUBE TESTS - Labcare diagnostics
AH, or BH). SAMPLE COLLECTION AND PRESERVATION. Fresh serum samples should be used. REAGENT PREPARATION AND STORAGE. The sample can be stored at 2-8°C if not ...Missing: Vi | Show results with:Vi
[36]
[PDF] WIDAL ANTIGENS - Labcare diagnostics
... Test tube rack. REAGENT STORAGE AND STABILITY. All reagents are stable up to the expiry date mentioned on the label when stored at 2-8°C. Do not freeze ...Missing: Vi | Show results with:Vi
[37]
One-Step 2-Minute Test To Detect Typhoid-Specific Antibodies ...
The Widal test uses a crude assay method to detect antibodies by their ability to agglutinate whole bacterial cells in test tubes. It is not surprising that the ...
[38]
https://onlinelibrary.wiley.com/doi/10.1155/2021/8279122
[39]
A Cross‐Sectional Comparative Study of the Performance of the ...
Aug 9, 2021 · Test Procedure for the Widal Slide Agglutination Test. The qualitative slide agglutination test was performed using febrile patient antigen ...
[40]
Comparative evaluation of slide agglutination and Widal tube ...
Aug 6, 2025 · The present study was done to comparatively evaluate the slide agglutination and Widal tube agglutination test in detecting enteric fever.Missing: paper | Show results with:paper<|control11|><|separator|>
[41]
Traditional Widal Agglutination Test Versus Rapid ... - NIH
Oct 4, 2021 · Widal is an agglutination test that is preferred during the second week of disease to support the clinical diagnosis [10]. Also, due to the low ...
[42]
[PDF] HiPer® Widal Test Teaching Kit (Tube Test) - HiMedia Laboratories
In this test four specific antigen suspensions are used e.g. H, Salmonella typhi (O antigen), Salmonella paratyphi - A and Salmonella paratyphi - B. If ...
[43]
[PDF] Stained Salmonella O and H Suspensions
The suspensions are suitable for use in rapid slide tests1 and standard Widal tests2,3. They may also be used as control antigens for serological identification ...
[44]
Laboratory Diagnosis of Paratyphoid Fever: Opportunity of Surface ...
This helps to avoid false negative results, due to Prozone phenomenon (high antibody (Ab) titer compared to the number of antigens (Ag)); 2.
[45]
Laboratory Diagnosis of Paratyphoid Fever: Opportunity of Surface ...
This test became known as the Widal test, and it is a conventional test to differentiate between typhoid and paratyphoid fever [33]. The core concept of the ...
[46]
Determination of Baseline Widal Titres Amongst Apparently Healthy ...
Present study was undertaken to establish the normal baseline titre in apparently healthy blood donors and also to determine cutoff values for the Widal test.
[47]
Widal Test in Diagnosis of Typhoid Fever in Turkey - ASM Journals
We concluded that O and H agglutinin titers of ≥1/200 are of diagnostic significance. The Widal test is easy, inexpensive, and relatively noninvasive. It can be ...
[48]
Distribution of antibody titer against Salmonella enterica among ...
Jan 7, 2009 · Widal agglutination test is an alternative laboratory test widely used for serological diagnosis of enteric fever in these settings. Developed ...
[49]
Retrospective Audit of the Widal Test for Diagnosis of Typhoid Fever ...
May 15, 2014 · Introduction: Although typhoid fever is confirmed by culture of Salmonella Typhi, Widal test is widely used in India but little information ...
[50]
Use of Paired Serum Samples for Serodiagnosis of Typhoid Fever
In its original form, the Widal test required two serum samples (acute and convalescent), with a fourfold rise in serum anti-LPS (TO) or anti-flagella (TH) ...
[51]
Diagnostics for Typhoid Fever: Current Perspectives and Future ...
Jun 2, 2023 · Various RDTs and different forms of the Widal test are commonly used in health facilities around the world to diagnose typhoid. These tests are ...
[52]
Comparative Evaluation of Various Tests for Diagnosis of ... - NIH
May 15, 2014 · False positive widal test results have been reported for patients with non typhoidal Salmonella, malaria and other immunological disorders [3].
[53]
False positive modified Widal test in acute malaria - PubMed
This test was positive in 14.58% and 10.41% of malaria patients for salmonella 'o' and 'H' titers respectively.
[54]
Widal Test - an overview | ScienceDirect Topics
... Typhidot, which detects both IgM and IgG to the 50kD antigen of S. Typhi, should be useful in identifying early acute infection [22]. However, in practice ...
[55]
False positive results in the Widal test in adults immunized with the ...
Aug 21, 2025 · The Widal test for the detection of typhoid fever is an antigen–antibody test that can be affected by vaccination, causing errors in the ...
[56]
Is the Widal Test Reliable for Typhoid Fever Diagnosis? - Away Clinic
Jan 17, 2023 · Antibiotics taken before testing can affect results, potentially leading to false negatives. The negative predictive value (NPV) of the Widal ...
[57]
[PDF] STAINED FEBRILE ANTIGENS - BIOLABO
It is necessary to perform all dilutions in the slide test to obviate the prozone effect where higher concentrations of the serum may give a negative result but ...Missing: phenomenon | Show results with:phenomenon
[58]
A Meta-Analysis of Typhoid Diagnostic Accuracy Studies - NIH
Nov 13, 2015 · This wide-ranging meta-analysis suggests that no single test has sufficiently good performance but some existing diagnostics may be useful as part of a CRS.
[59]
The Baseline Widal Titre Among the Healthy Individuals of the Hilly ...
In these settings, the Widal test, a serological test which was developed by Georges Fernand Isidore Widal in 1896, is an alternative to the microbial culture, ...
[60]
Comparative Study on the Use of Widal Test to Stool Culture in the ...
Mar 28, 2019 · 1. Widal Slide Agglutination Test Procedure. The Swemed diagnostic Widal test kit was used to perform Widal test and was carried out in ...INTRODUCTION · MATERIALS AND METHODS · RESULTS
[61]
Evaluation of false negativity of the Widal test among culture proven ...
Aug 6, 2025 · Age was found to be a possible factor for a false negative Widal test (p=0.06). ... age should be considered in cases of Widal test negativity.<|separator|>
[62]
The utility of diagnostic tests for enteric fever in endemic locations
Jan 10, 2014 · In endemic areas, diagnostic tests are needed to diagnose acute cases for clinical management, to detect convalescent and chronic fecal carriage and for ...
[63]
Diagnosis and Treatment of Typhoid Fever and Associated ...
Widal test. Qualitative slide and semi quantitative tube agglutination methods were done using febrile antigen kits of Salmonella typhi (Chromatest Febrile ...
[64]
Enteric fever and the diagnostic tools: defining the accuracy - Frontiers
Jan 28, 2024 · The Widal test quantifies the agglutinating antibodies for the antigen of S. typhi, in particular lipopolysaccharide and flagella in the serum ...
[65]
Widal Test- Principle, Procedure, Types, Results, Uses
Feb 5, 2022 · This test was introduced in 1896 by a French physician and bacteriologist Georges Fernand Isidor Widal (March 9, 1862, to January 14, 1929).<|separator|>
[66]
A Meta-Analysis of Typhoid Diagnostic Accuracy Studies
If no single gold standard test exists, use of a composite reference standard (CRS) can improve estimation of diagnostic accuracy. Numerous studies have used a ...
[67]
Seroprevalence of Typhoid Fever and Its Associated Risk Factors ...
Jan 31, 2025 · The prevalence of this disease ranges from 160 per 100,000 people in sub-Saharan Africa to 0.3 per 100,000 people in Europe [3]. According to ...Abstract · Introduction · Materials and Methods · Results
[68]
Epidemiological Investigation of a Typhoid Outbreak - PMC
Out of 92 blood samples sent, five (5.43%) blood culture samples were positive for Salmonella typhi. Eighty-six (87.75%) blood samples were positive for Widal ...
[69]
Can better diagnostics improve typhoid prevention and treatment?
Feb 20, 2025 · The Widal test, a widely used rapid diagnostic for typhoid, is simple and inexpensive and provides results within minutes. However, its ...
[70]
Vi serology in detection of chronic Salmonella typhi carriers in an ...
This simple assay can screen for chronic S typhi carriers even in areas where typhoid fever is highly endemic.
[71]
https://www.ijidonline.com/article/S1201-9712(05)00176-1/fulltext
[72]
Evaluating alternatives to the Widal test for typhoid fever diagnosis ...
The different studies in this review have shown that the Widal test performs poorly in identifying typhoid infections compared to other rapid diagnostic tests ...
[73]
Performance of Widal test and stool culture in the diagnosis of ... - NIH
Jun 5, 2019 · Widal test is not reliable for diagnosis of typhoid fever since false positive and negative results are common.